The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
Open Access
- 29 March 2023
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 60 (7) , 3898-3910
Abstract
The fragile X protein (FXP) family comprises the multifunctional RNA-binding proteins FMR1, FXR1, and FXR2 that play an important role in RNA metabolism and regulation of translation, but also in DNA damage and cellular stress responses, mitochondrial organization, and more. FMR1 is well known for its implication in neurodevelopmental diseases. Recent evidence suggests substantial contribution of this protein family to amyotrophic lateral sclerosis (ALS) pathogenesis. ALS is a highly heterogeneous neurodegenerative disease with multiple genetic and unclear environmental causes and very limited treatment options. The loss of motoneurons in ALS is still poorly understood, especially because pathogenic mechanisms are often restricted to patients with mutations in specific causative genes. Identification of converging disease mechanisms evident in most patients and suitable for therapeutic intervention is therefore of high importance. Recently, deregulation of the FXPs has been linked to pathogenic processes in different types of ALS. Strikingly, in many cases, available data points towards loss of expression and/or function of the FXPs early in the disease, or even at the presymptomatic state. In this review, we briefly introduce the FXPs and summarize available data about these proteins in ALS. This includes their relation to TDP-43, FUS, and ALS-related miRNAs, as well as their possible contribution to pathogenic protein aggregation and defective RNA editing. Furthermore, open questions that need to be addressed before definitively judging suitability of these proteins as novel therapeutic targets are discussed.Keywords
Funding Information
- Universität Ulm
This publication has 99 references indexed in Scilit:
- Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neuronsActa Neuropathologica, 2013
- Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editingNucleic Acids Research, 2012
- TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexesProceedings of the National Academy of Sciences, 2012
- Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation proteinNature Neuroscience, 2011
- Mapping a Dynamic Innate Immunity Protein Interaction Network Regulating Type I Interferon ProductionImmunity, 2011
- Cellular stress-induced up-regulation of FMRP promotes cell survival by modulating PI3K-Akt phosphorylation cascadesJournal of Biomedical Science, 2011
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- miRNA malfunction causes spinal motor neuron diseaseProceedings of the National Academy of Sciences, 2010
- Cells Lacking the Fragile X Mental Retardation Protein (FMRP) have Normal RISC Activity but Exhibit Altered Stress Granule AssemblyMolecular Biology of the Cell, 2009
- The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18aNature Structural & Molecular Biology, 2007